Affinity Asset Advisors’s Mersana Therapeutics MRSN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-30,680
| Closed | -$1.54M | – | 88 |
|
|
2024
Q2 | $1.54M | Sell |
30,680
-9,320
| -23% | -$468K | 0.18% | 64 |
|
|
2024
Q1 | $4.48M | Hold |
40,000
| – | – | 0.55% | 43 |
|
|
2023
Q4 | $2.32M | Sell |
40,000
-74,000
| -65% | -$4.29M | 0.42% | 47 |
|
|
2023
Q3 | $3.62M | Buy |
+114,000
| New | +$3.62M | 1.02% | 27 |
|
|
2021
Q3 | – | Sell |
-3,400
| Closed | -$1.15M | – | 82 |
|
|
2021
Q2 | $1.15M | Hold |
3,400
| – | – | 0.41% | 44 |
|
|
2021
Q1 | $1.38M | Buy |
3,400
+1,400
| +70% | +$566K | 0.47% | 35 |
|
|
2020
Q4 | $1.33M | Buy |
+2,000
| New | +$1.33M | 0.71% | 31 |
|